Sriharsha  Tella  to  Female
                            
                            
                                This is a "connection" page, showing publications  Sriharsha  Tella  has written about  Female.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.266
         
        
        
     
 
    
        
        - 
            Novel staging system using carbohydrate antigen (CA) 19-9 in extra-hepatic cholangiocarcinoma and its implications on overall survival. Eur J Surg Oncol. 2020 05; 46(5):789-795.
            
            
                Score: 0.036
             
- 
            Association Between Hospital Volume, Therapy Types, and Overall Survival in Stage III and IV Cutaneous Malignant Melanoma. J Natl Compr Canc Netw. 2019 11 01; 17(11):1334-1342.
            
            
                Score: 0.036
             
- 
            Survival and prognostic factors in patients with pancreatic squamous cell carcinoma. Eur J Surg Oncol. 2019 Sep; 45(9):1700-1705.
            
            
                Score: 0.034
             
- 
            Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database. J Clin Endocrinol Metab. 2018 09 01; 103(9):3566-3573.
            
            
                Score: 0.033
             
- 
            Incidence, racial disparities and survival outcomes of mast cell malignancies: analysis from a national database. Leuk Lymphoma. 2018 09; 59(9):2254-2257.
            
            
                Score: 0.031
             
- 
            Association Between Iron-Deficiency Anemia and Hypophosphatemia. Am J Med. 2018 03; 131(3):e103-e104.
            
            
                Score: 0.031
             
- 
            Association Between Treatment Facility Volume, Therapy Types, and Overall Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer. J Natl Compr Canc Netw. 2019 03 01; 17(3):229-236.
            
            
                Score: 0.009
             
- 
            Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma. HPB (Oxford). 2019 03; 21(3):379-386.
            
            
                Score: 0.008
             
- 
            Fluoroquinolone-associated suicide. Eur J Intern Med. 2018 09; 55:e21-e22.
            
            
                Score: 0.008
             
- 
            A population-based analysis of second primary malignancies in T-cell neoplasms. Br J Haematol. 2019 04; 185(2):338-342.
            
            
                Score: 0.008
             
- 
            T cell/histiocyte-rich large B cell lymphoma: incidence, demographic disparities, and long-term outcomes. Br J Haematol. 2019 04; 185(1):140-142.
            
            
                Score: 0.008
             
- 
            Natural Killer/T-cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States. Clin Lymphoma Myeloma Leuk. 2018 07; 18(7):475-479.
            
            
                Score: 0.008
             
- 
            A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer. Breast Cancer Res Treat. 2018 Aug; 170(3):677-685.
            
            
                Score: 0.008
             
- 
            Histiocytic sarcoma: a population-based analysis of incidence, demographic disparities, and long-term outcomes. Blood. 2018 01 11; 131(2):265-268.
            
            
                Score: 0.008